Cargando…

Podophyllotoxin reduces the aggressiveness of human oral squamous cell carcinoma through myeloid cell leukemia-1

Podophyllotoxin (PPT), which is derived from the podophyllum plant, exhibits marked cytotoxic effects against cancer cells; however, the precise molecular mechanism underlying its activity against human oral squamous cell carcinoma (OSCC) has not been elucidated. In the present study, the mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Hyun-Ju, Shin, Ji-Ae, Choi, Su-Jung, Cho, Sung-Dae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619536/
https://www.ncbi.nlm.nih.gov/pubmed/37711052
http://dx.doi.org/10.3892/ijmm.2023.5306
_version_ 1785130009193611264
author Yu, Hyun-Ju
Shin, Ji-Ae
Choi, Su-Jung
Cho, Sung-Dae
author_facet Yu, Hyun-Ju
Shin, Ji-Ae
Choi, Su-Jung
Cho, Sung-Dae
author_sort Yu, Hyun-Ju
collection PubMed
description Podophyllotoxin (PPT), which is derived from the podophyllum plant, exhibits marked cytotoxic effects against cancer cells; however, the precise molecular mechanism underlying its activity against human oral squamous cell carcinoma (OSCC) has not been elucidated. In the present study, the mechanism by which PPT induced cytotoxicity in two OSCC cell lines, HSC3 and HSC4, was determined. The effects of PPT on cytotoxicity in HSC3 and HSC4 cells were analyzed using Annexin V/PI double staining, Sub-G(1) analysis, soft agar assays, western blotting, and quantitative PCR. The changes in the mitochondrial membrane potential were assessed using a JC-1 assay and cytosolic and mitochondrial fractionation. A myeloid cell leukemia-1 (Mcl-1) overexpression cell lines were also established to study the role of Mcl-1 on apoptosis. The results showed that PPT inhibited the growth of the two human OSCC cell lines and induced apoptosis, which was accompanied by mitochondrial membrane depolarization. Compared with the control, PPT reduced the expression of Mcl-1 in both cell lines through a proteasome-dependent protein degradation process. Overall, these results suggested that targeting of Mcl-1 protein by PPT induced apoptosis, providing a foundation for further pre-clinical and clinical study of its value in the management of OSCC.
format Online
Article
Text
id pubmed-10619536
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-106195362023-11-02 Podophyllotoxin reduces the aggressiveness of human oral squamous cell carcinoma through myeloid cell leukemia-1 Yu, Hyun-Ju Shin, Ji-Ae Choi, Su-Jung Cho, Sung-Dae Int J Mol Med Articles Podophyllotoxin (PPT), which is derived from the podophyllum plant, exhibits marked cytotoxic effects against cancer cells; however, the precise molecular mechanism underlying its activity against human oral squamous cell carcinoma (OSCC) has not been elucidated. In the present study, the mechanism by which PPT induced cytotoxicity in two OSCC cell lines, HSC3 and HSC4, was determined. The effects of PPT on cytotoxicity in HSC3 and HSC4 cells were analyzed using Annexin V/PI double staining, Sub-G(1) analysis, soft agar assays, western blotting, and quantitative PCR. The changes in the mitochondrial membrane potential were assessed using a JC-1 assay and cytosolic and mitochondrial fractionation. A myeloid cell leukemia-1 (Mcl-1) overexpression cell lines were also established to study the role of Mcl-1 on apoptosis. The results showed that PPT inhibited the growth of the two human OSCC cell lines and induced apoptosis, which was accompanied by mitochondrial membrane depolarization. Compared with the control, PPT reduced the expression of Mcl-1 in both cell lines through a proteasome-dependent protein degradation process. Overall, these results suggested that targeting of Mcl-1 protein by PPT induced apoptosis, providing a foundation for further pre-clinical and clinical study of its value in the management of OSCC. D.A. Spandidos 2023-09-11 /pmc/articles/PMC10619536/ /pubmed/37711052 http://dx.doi.org/10.3892/ijmm.2023.5306 Text en Copyright: © Yu et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Yu, Hyun-Ju
Shin, Ji-Ae
Choi, Su-Jung
Cho, Sung-Dae
Podophyllotoxin reduces the aggressiveness of human oral squamous cell carcinoma through myeloid cell leukemia-1
title Podophyllotoxin reduces the aggressiveness of human oral squamous cell carcinoma through myeloid cell leukemia-1
title_full Podophyllotoxin reduces the aggressiveness of human oral squamous cell carcinoma through myeloid cell leukemia-1
title_fullStr Podophyllotoxin reduces the aggressiveness of human oral squamous cell carcinoma through myeloid cell leukemia-1
title_full_unstemmed Podophyllotoxin reduces the aggressiveness of human oral squamous cell carcinoma through myeloid cell leukemia-1
title_short Podophyllotoxin reduces the aggressiveness of human oral squamous cell carcinoma through myeloid cell leukemia-1
title_sort podophyllotoxin reduces the aggressiveness of human oral squamous cell carcinoma through myeloid cell leukemia-1
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619536/
https://www.ncbi.nlm.nih.gov/pubmed/37711052
http://dx.doi.org/10.3892/ijmm.2023.5306
work_keys_str_mv AT yuhyunju podophyllotoxinreducestheaggressivenessofhumanoralsquamouscellcarcinomathroughmyeloidcellleukemia1
AT shinjiae podophyllotoxinreducestheaggressivenessofhumanoralsquamouscellcarcinomathroughmyeloidcellleukemia1
AT choisujung podophyllotoxinreducestheaggressivenessofhumanoralsquamouscellcarcinomathroughmyeloidcellleukemia1
AT chosungdae podophyllotoxinreducestheaggressivenessofhumanoralsquamouscellcarcinomathroughmyeloidcellleukemia1